These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 27433579)
21. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles. Zuccari G; Carosio R; Fini A; Montaldo PG; Orienti I J Control Release; 2005 Mar; 103(2):369-80. PubMed ID: 15763620 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. Schwartz EL; Hallam S; Gallagher RE; Wiernik PH Biochem Pharmacol; 1995 Sep; 50(7):923-8. PubMed ID: 7575674 [TBL] [Abstract][Full Text] [Related]
23. Novel mutual prodrug of retinoic and butyric acids with enhanced anticancer activity. Nudelman A; Rephaeli A J Med Chem; 2000 Jul; 43(15):2962-6. PubMed ID: 10956204 [TBL] [Abstract][Full Text] [Related]
24. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles. Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751 [TBL] [Abstract][Full Text] [Related]
25. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Ridolfi DM; Marcato PD; Justo GZ; Cordi L; Machado D; Durán N Colloids Surf B Biointerfaces; 2012 May; 93():36-40. PubMed ID: 22244299 [TBL] [Abstract][Full Text] [Related]
26. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA). Narvekar M; Xue HY; Wong HL Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of all-trans retinoic acid-induced differentiation by pH-sensitive nanoparticles for solid tumor cells. Wang Y; Wang H; Lv X; Liu C; Qi L; Song X; Yu A Macromol Biosci; 2014 Mar; 14(3):369-79. PubMed ID: 24115498 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Immunomodulatory Effects of All-Trans Retinoic Acid Solid Lipid Nanoparticles and Human Mesenchymal Stem Cells in an A549 Epithelial Cell Line Model. Payne CM; Burke LP; Cavanagh B; O'Toole D; Cryan SA; Kelly HM Pharm Res; 2019 Feb; 36(4):50. PubMed ID: 30761406 [TBL] [Abstract][Full Text] [Related]
29. A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results. Coradini D; Pellizzaro C; Scarlata I; Zorzet S; Garrovo C; Abolafio G; Speranza A; Fedeli M; Cantoni S; Sava G; Daidone MG; Perbellini A Leukemia; 2006 May; 20(5):785-92. PubMed ID: 16525489 [TBL] [Abstract][Full Text] [Related]
30. Polymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxel. Zhang J; Han J; Zhang X; Jiang J; Xu M; Zhang D; Han J Carbohydr Polym; 2015 Sep; 129():25-34. PubMed ID: 26050884 [TBL] [Abstract][Full Text] [Related]
31. Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression. Xu K; Guidez F; Glasow A; Chung D; Petrie K; Stegmaier K; Wang KK; Zhang J; Jing Y; Zelent A; Waxman S Cancer Res; 2005 Sep; 65(17):7856-65. PubMed ID: 16140955 [TBL] [Abstract][Full Text] [Related]
32. Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells. Gui K; Zhang X; Chen F; Ge Z; Zhang S; Qi X; Sun J; Yu Z Biomed Pharmacother; 2019 Mar; 111():751-764. PubMed ID: 30612000 [TBL] [Abstract][Full Text] [Related]
33. PEG-PLA diblock copolymer micelle-like nanoparticles as all-trans-retinoic acid carrier: in vitro and in vivo characterizations. Li Y; Qi XR; Maitani Y; Nagai T Nanotechnology; 2009 Feb; 20(5):055106. PubMed ID: 19417337 [TBL] [Abstract][Full Text] [Related]
34. Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells. Ohnuma-Ishikawa K; Morio T; Yamada T; Sugawara Y; Ono M; Nagasawa M; Yasuda A; Morimoto C; Ohnuma K; Dang NH; Hosoi H; Verdin E; Mizutani S Cancer Res; 2007 Feb; 67(3):1019-29. PubMed ID: 17283134 [TBL] [Abstract][Full Text] [Related]
35. Micellar complexes of all-trans retinoic acid with polyvinylalcohol-nicotinoyl esters as new parenteral formulations in neuroblastoma. Zuccari G; Bergamante V; Carosio R; Gotti R; Montaldo PG; Orienti I Drug Deliv; 2009 May; 16(4):189-95. PubMed ID: 19241235 [TBL] [Abstract][Full Text] [Related]
36. Partial restoration of all trans retinoic acid (ATRA) sensitivity by compactin in ATRA-resistant leukemic cells (ATRA-R HL-60). Gueddari N; Madoulet C; Lefebvre P; Berthou L; Chomienne C; Jardillier JC Leuk Res; 2000 Jun; 24(6):543-8. PubMed ID: 10781690 [TBL] [Abstract][Full Text] [Related]
37. Development of a validated UPLC method for simultaneous estimation of both free and entrapped (in solid lipid nanoparticles) all-trans retinoic acid and cholecalciferol (vitamin D3) and its pharmacokinetic applicability in rats. Kumar M; Sharma G; Singla D; Singh S; Sahwney S; Chauhan AS; Singh G; Kaur IP J Pharm Biomed Anal; 2014 Mar; 91():73-80. PubMed ID: 24440824 [TBL] [Abstract][Full Text] [Related]
38. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233 [TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles. Zhang T; Xiong H; Dahmani FZ; Sun L; Li Y; Yao L; Zhou J; Yao J Nanotechnology; 2015 Apr; 26(14):145101. PubMed ID: 25771790 [TBL] [Abstract][Full Text] [Related]
40. Modulation of the activity of the human cholesteryl ester transfer protein by carboxylated derivatives. Evidence for 13-cis-retinoic acid as a potent activator of the protein's activity in plasma. Florentin E; Athias A; Lagrost L Eur J Biochem; 1996 Sep; 240(3):699-706. PubMed ID: 8856073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]